Exosome Technology Licensed to PranaX Published in Nature Communications
PranaX Corporation, a leading biotechnology company specializing in regenerative biologics, has announced that a study concerning the exosome manufacturing technology exclusively licensed for non-cancer indications from The University of Texas MD Anderson Cancer Center was published inNature Communications. The study was led by Valerie S. Kalluri, MD/PhD, MBA and Raghu Kalluri MD/PhD, both scientific co-founders […]